Log in

ORIONINFU Orion Infusion Ltd. DSEBD · Bangladesh

Orion Infusion (ORIONINFU) news

Orion Infusion Ltd. is a public biotech or pharmaceutical company listed on DSEBD under the ticker ORIONINFU, recorded under Bangladesh. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Orion Infusion news

We have not published a story on Orion Infusion yet. When there is news, it will appear here.

Questions about Orion Infusion

What is the ticker symbol of Orion Infusion?

Orion Infusion Ltd. trades under the ticker ORIONINFU on DSEBD.

Where is Orion Infusion listed?

Orion Infusion Ltd. is listed on DSEBD.

Which country or territory is Orion Infusion listed under?

Our directory records Orion Infusion Ltd. under Bangladesh.

What does Orion Infusion do?

Our directory classifies Orion Infusion Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Orion Infusion?

The ISIN recorded for Orion Infusion Ltd. is BD0472ORINF6.

Does aibio.space cover Orion Infusion?

aibio.space lists Orion Infusion Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Orion Infusion?

Companies in our directory listed in the same country and business area as Orion Infusion: Techno Drugs, Advent Pharma, Beacon Pharmaceuticals, Central Pharmaceuticals, Square Pharmaceuticals, Indo-Bangla Pharmaceuticals.

Investor discussion: Orion Infusion

Members talk about Orion Infusion (ORIONINFU). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Orion Infusion Ltd. is a public biotech or pharmaceutical company listed on DSEBD under the ticker ORIONINFU, recorded under Bangladesh. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Orion Infusion Ltd.
Ticker
ORIONINFU
Listing
DSEBD
Country or territory
Bangladesh
Business scope
Pharmaceuticals: Major
ISIN
BD0472ORINF6
Last quote in directory
2026-10-19
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.